CNR Institutional Research Information System

CUTRUPI, SEBASTIANO

CUTRUPI, SEBASTIANO  

Istituto di Fisiologia Clinica - IFC  

Mostra records
Risultati 1 - 20 di 93 (tempo di esecuzione: 0.024 secondi).
Titolo Data di pubblicazione Autore(i) File
Adiponectin is markedly increased in patients with nephrotic syndrome and is related to metabolic risk factors. 1-gen-2003 Zoccali, C; Mallamaci, F; Panuccio, V; Tripepi, G; Cutrupi, S; Parlongo, S; Catalano, F; Tanaka, S; Ouchi, N; Kihara, S; Funahashi, T; Matsuzawa, Y
Adiponectin, the most abundant adipocyte-derived protein, is functionally related to metabolic risk factors and predicts cardiovascular events in patients with end stage renal disease 1-gen-2002 Zoccali C; Mallamaci F; Tripepi G; Benedetto F. A; Cutrupi S; Parlongo S; Malatino L; Bonanno G; Rapisarda F; Fatuzzo P; Buemi M; Nicocia G; Tanaka S; Ouchi N; Kihara S; Funahashi T; Matsuzawa Y.
Adipose tissue cytokines, insulin sensitivity, inflammation, and cardiovascular outcome stage renal disease patients. 1-gen-2005 Zoccali, C; Tripepi, G; Cambareri, F; Catalano, F; Finocchiaro, P; Cutrupi, S; Pizzini, P; Testa, A; Spoto, B; Panuccio, V; Enia, G; Mallamaci, F
Asymmetric dimethyl-arginine (ADMA) response to inflammation in acute infections 1-gen-2007 Zoccali C; Maas R; Cutrupi S; Pizzini P; Finocchiaro P; Cambareri F; Panuccio V; Martorano C; Schulze F; Enia G; Tripepi G; Boger R
Asymmetrical Di-Methyl-Arginine (ADMA) predicts progression to dialysis and death in patients with chronic kidney disease (CKD). 1-gen-2005 Ravani, P; Malberti, F; Testa, S; Cutrupi, S; Pizzini, P; Tripepi, G; Mallamaci, F; Zoccali, C
Beyond bone mineral metabolism: functional relationship with inflammation in chronic kidney disease (CKD) patients. 1-gen-2009 Zoccali, C; Leonardis, D; Catalano, F; Caridi, G; Finocchiaro, P; Panuccio, V; Cutrupi, S; Pizzini, P; Tripepi, G; Mallamaci, F
C-Reactive Protein and Interleukin-6 modify the risk of high levels of Asymmetric Dimethyl-Arginine (ADMA) for death and cardiovascular events in end stage renal diseases patients. 1-gen-2010 Tripepi G.; Boeger R.; R.Maas R.; Pizzini P.; Cutrupi S.; Zoccali C.
Chlamydia pneumoniae, overall and cardiovascular mortality in end-stage renal disease (ESRD). 1-gen-2003 Zoccali, C; Mallamaci, F; Tripepi, G; Parlongo, S; Cutrupi, S; Benedetto, Fa; Bonanno, G; Seminara, G; Fatuzzo, P; Rapisarda, F; Malatino, Ls
Circulating soluble RAGE in patients with chronic kidney disease as an inverse correlate of atherosclerosis. 1-gen-2009 Leonardis, D; Basta, G; Mallamaci, F; Cutrupi, S; Pizzini, P; De Caterina, R; Tripepi, R; Tripepi, G; Zoccali, C
Circulating soluble RAGE in patients with chronic kidney disease as an inverse correlate of atherosclerosis. 1-gen-2009 Leonardis, D; Basta, G; Mallamaci, F; Cutrupi, S; Pizzini, P; De Caterina, R; Tripepi, R; Tripepi, G; Zoccali, C
Circulating soluble receptor for advanced glycation end product (sRAGE) and left ventricular hypertrophy in patients with chronic kidney disease (CKD) 1-gen-2012 Leonardis, D; Basta, G; Mallamaci, F; Cutrupi, S; Pizzini, P; Tripepi, R; Tripepi, G; De Caterina, R
Circulating soluble receptor of advanced glycation end product inversely correlates with atherosclerosis in patients with chronic kidney disease 1-gen-2010 Basta, G; Leonardis, D; Mallamaci, F; Cutrupi, S; Pizzini, P; Gaetano, L; Tripepi, R; Tripepi, G; De Caterina, R; Zoccali, C
Diagnostic value for low bone turnover of first and second generation immuno-radiometric PTH assay. 1-gen-2003 Enia, G; Cutrupi, S; Pizzini, P; Tripepi, G; Mallamaci, F; Panuccio, V; Zoccali, C
Diagnostic value of troponin-t for alterations in left ventricular mass and function in dialysis patients 1-gen-2002 Mallamaci F; Zoccali C; Parlongo S; Tripepi G.; Benedetto F. A.; Cutrupi S.; Bonanno G; Fatuzzo P.; Rapisarda F.; Seminara G.; Stancanelli B.; Bellanuova I.; Cataliotti A.; Malatino L. S.
Does sub-clinical hypothyroidism predict survival in patients on Continuous Ambulatory Peritoneal Dialysis? 1-gen-2006 Enia G; Cutrupi S; Pizzini P; Tripepi G; Zoccali C.
Effect of inflammation by acute sepsis on intact fibroblast growth factor 23 (iFGF23) and asymmetric dimethyl arginine (ADMA) in CKD patients 1-gen-2016 Dounousi E.; Torino C.; Pizzini P.; Cutrupi S.; Panuccio V.; D'Arrigo G.; Abd ElHafeez S.; Tripepi G.; Mallamaci F.; Zoccali C.
Effect of simvastatin on plasma asymmetric dimethylarginine concentration in patients with chronic kidney disease. 1-gen-2008 Panichi, V; Mantuano, E; Paoletti, S; Santi, S; Manca Rizza, G; Cutrupi, S; Pizzini, P; Spoto, B; Tripepi, G; Zoccali, C
FGF23 beyond bone mineral metabolism: functional relationship with inflammation in chronic kidney disease patients. 1-gen-2009 Zoccali, C; Leonardis, D; Catalano, F; Caridi, G; Finocchiaro, P; Panuccio, V; Cutrupi, S; Pizzini, P; Tripepi, G; Mallamaci, F
Fibrinogen, inflammation and concentric left ventricular hypertrophy in chronic renal failure. 1-gen-2003 Zoccali, C; Benedetto, Fa; Mallamaci, F; Tripepi, G; Cutrupi, S; Parlongo, S; Malatino, Ls; Bonanno, G; Rapisarda, F; Fatuzzo, P; Seminara, G; Nicocia, G; Buemi, M
Fibrinogen, mortality and incident cardiovascular complications in end-stage renal failure. 1-gen-2003 Zoccali C;Mallamaci F; Tripepi G; Cutrupi S; Parlongo S; Malatino LS; Bonanno G; .Rapisarda F; Fatuzzo P; Seminara G; Stancanelli B; Nicocia G;Buemi M.